JOHNSON & JOHNSON
424B3, 2000-08-16
PHARMACEUTICAL PREPARATIONS
Previous: MANN HORACE LIFE INSURANCE CO SEPARATE ACCOUNT, 497, 2000-08-16
Next: DANIELSON HOLDING CORP, S-3/A, 2000-08-16





Prospectus Supplement                          Filed Pursuant to Rule 424(b)(3)
(To Prospectus dated December 29, 1999)              Registration No. 333-91349



                              Johnson & Johnson

                                792,660 Shares
                                 Common Stock

                                  $61,107,000
                                  Guarantees

          This prospectus supplement contains information about the persons
who can use this prospectus supplement to offer and sell shares of Johnson &
Johnson's common stock those persons own and, together with Centocor's 4 3/4%
Convertible Subordinated Debentures due 2005 those persons own, Johnson &
Johnson's guarantees those persons own of those debentures.


                            SELLING SECURITYHOLDERS

          The information set forth in the table under the caption "Selling
Securityholders" in the Johnson & Johnson prospectus dated December 29, 1999,
relating to Johnson & Johnson common stock and Johnson & Johnson guarantees,
as supplemented on March 24, 2000, April 17, 2000, May 5, 2000 and August 1,
2000, is supplemented to add the following:

<TABLE>
<CAPTION>

                                        Common Stock                                     Guarantees
                            ---------------------------------     -------------------------------------------------------
                                                 Number of        Principal                               Principal
                              Shares               Shares           Amount          Percentage of           Amount
Name of Selling            Beneficially        Registered for     Beneficially        Outstanding        Registered for
Securityholder (1)           Owned (2)         Sale Hereby(3)       Owned($)          Guarantees          Sale Hereby($)
<S>                        <C>                 <C>                <C>                <C>                 <C>
Thomas L. Rinker              259                   259              20,000               *                  20,000
</TABLE>

---------------

(1)      The information set forth herein is as of August 16, 2000.

(2)      Assumes conversion of the full amount of the unrestricted and
         restricted Centocor debentures held by such holder at the conversion
         price in effect as of August 16, 2000 of $77.091 per share of Johnson
         & Johnson common stock. Fractional shares will not be issued upon
         conversion of the Centocor debentures; cash will be paid in lieu of
         any fractional shares.

(3)      Assumes conversion of the full amount of the restricted Centocor
         debentures held by such holder at the conversion price in effect as
         of August 16, 2000 of $77.091 per share of Johnson & Johnson common
         stock. Fractional shares will not be issued upon conversion of the
         Centocor debentures; cash will be paid in lieu of any fractional
         shares. This prospectus also covers any additional shares of Johnson
         & Johnson common stock which become issuable in connection with the
         shares registered for sale hereby by reason of any stock dividend,
         stock split, recapitalization or other similar transaction effected
         without the receipt of consideration which results in an increase in
         the number of outstanding shares of Johnson & Johnson common stock.

   * Represents beneficial ownership of less than 1% of the aggregate
principal amount of Johnson & Johnson guarantees outstanding as of August 16,
2000.


                The date of this prospectus is August 16, 2000.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission